Journal Article

Oltipraz regulates different categories of genes relevant to chemoprevention in human hepatocytes

Amélie Piton, Eric Le Ferrec, Sophie Langouët, Claudine Rauch, Elise Petit, Frédérick Le Goff, André Guillouzo and Fabrice Morel

in Carcinogenesis

Volume 26, issue 2, pages 343-351
Published in print February 2005 | ISSN: 0143-3334
Published online February 2005 | e-ISSN: 1460-2180 | DOI: http://dx.doi.org/10.1093/carcin/bgh316
Oltipraz regulates different categories of genes relevant to chemoprevention in human hepatocytes

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

Numerous chemical compounds are cytotoxic or carcinogenic to human beings and attention is now focusing on preventative strategies. One agent, oltipraz (OPZ), regarded as one of the most promising chemoprotectors, has been shown to be a potent inducer of phase II enzymes involved in the detoxification of carcinogens, including aflatoxins. However, little is known about its effects on global gene expression in human cells. Thus, we used microarrays and reverse transcription–quantitative polymerase chain reaction to test the effects of OPZ on the overall pattern of mRNA expression of multiple metabolic pathways in human hepatocytes in primary culture. Our results show for the first time that OPZ significantly alters the expression of human genes within different functional categories (detoxification of xenobiotics, antioxidant defences, xenobiotic transport, cell cycle and stress responses), at both the mRNA and protein levels, some of which are highly relevant to chemoprevention. Amongst these genes, several have never been described as being regulated by OPZ before. We also demonstrate variations in response to OPZ, depending on the individual from whom the cells were derived, that might potentially contribute to differences in efficacy of chemopreventive treatments between individuals. Moreover, comparison of our results with those obtained in rodents demonstrates species differences in response to OPZ for some genes, underlying the importance of studies on human cells to predict the effects of chemopreventive agents.

Keywords: CYP, cytochrome P450; GST, glutathione S-transferase; HL, human liver; OPZ, oltipraz; ROS, reactive oxygen species; RT-qPCR, reverse transcription–quantitative polymerase chain reaction; TBS, Tris-buffered saline

Journal Article.  5391 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.